Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Opica AB has announced bid regarding Capio AB
Mandate

Opica AB has announced bid regarding Capio AB

September 13, 2006

Capio AB is an European health care group company with operations in English, Spain, France and the Nordic region. The company is owned indirectly by Apax Europe, Nordic Capital and Apax France. The bid corresponds to a total of all shares in Capio for SEK 15.6 billion.

Vinge acted as advisor to Opica AB. Representatives from Vinge included Carl Gustaf De Geer, Göran Nyström, Malin Leffler, Fabian Ekeblad, Carl Wetter, Ola Sandersson, Sara Mindus and Sara Axelsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026